Individualizing 2L+ CLL Therapy
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Released: September 13, 2024

Expiration: September 12, 2025

Jeremy S. Abramson
Jeremy S. Abramson, MD, MMSc
Farrukh T. Awan
Farrukh T. Awan, MD, MS, MBA
Shuo Ma
Shuo Ma, MD, PhD

Activity

Progress
1
Course Completed